| De-stiffening drug therapy and blood pressure control. | |
| | |
MedLine Citation:
|
PMID: 21949616 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
In hypertensive subjects, cardiovascular risk reduction is critically related to the decrease of systolic blood pressure (SBP). De-stiffening therapy means that, in a controlled therapeutic trial of long duration, a selective reduction of SBP has been obtained in the studied group by comparison with the control group, and that this SBP reduction is due to a decrease of either arterial stiffness, or wave reflections, or both. Central SBP reduction and cardiovascular remodeling are specifically involved. Most protocols require the presence of an angiotensin II blocker, potentially associated with a diuretic compound and/or a calcium-channel blocker. Cardiovascular outcomes are significantly reduced by comparison with the control group, particularly when this latter group involves administration of a beta-blocking agent. |
| | |
Authors:
|
Michel E Safar |
Related Documents
:
|
18199346 - Cavernous body reduction in four patients with erectile dysfunction due to insufficient... 4704496 - Direct arterial pressure and electrocardiogram during motor car driving. 11164736 - Sustained reduction of portal pressure by administration of octreotide-lar in portal hy... 15878216 - Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepa... 10459786 - Older subjects show no age-related decrease in cardiac baroreceptor sensitivity. 3718646 - Epidemiology and management of severe symptomatic neonatal hypertension. |
Publication Detail:
|
Type: Journal Article Date: 2010-01-29 |
Journal Detail:
|
Title: Integrated blood pressure control Volume: 3 ISSN: 1178-7104 ISO Abbreviation: Integr Blood Press Control Publication Date: 2010 |
Date Detail:
|
Created Date: 2011-09-28 Completed Date: 2011-11-10 Revised Date: 2012-04-27 |
Medline Journal Info:
|
Nlm Unique ID: 101562709 Medline TA: Integr Blood Press Control Country: New Zealand |
Other Details:
|
Languages: eng Pagination: 1-9 Citation Subset: - |
Affiliation:
|
Paris-Descartes University, Faculty of Medicine, Hôtel-Dieu Hospital, AP-HP, Diagnosis Center, Paris, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Current concepts in combination therapy for the treatment of hypertension: combined calcium channel ...
Next Document: Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapa...